Acrylic Acid

Acrylic Acid

SCHEMBL29670988

C=CC(=O)O.C=CC(=O)O.C=CC(=O)O.C=CC(=O)O.CCCCCC(CO)(CO)CO.CCCCCC(CO)(CO)CO

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ZDHHC20 Q5W0Z9 1/20 0.39
ZDHHC2 Q9UIJ5 1/20 0.39
LMNA P02545 1/20 0.39
TSHR P16473 4/20 0.37
ALDH1A1 P00352 3/20 0.37
TP53 P04637 1/20 0.37
CYP3A4 P08684 1/20 0.37
MAPK1 P28482 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HIF1A Q16665 1/20 0.37
HPGD P15428 1/20 0.37
CES2 O00748 1/20 0.36
AKR1B1 P15121 1/20 0.35
PPARG P37231 4/20 0.34
PPARD Q03181 4/20 0.34
PPARA Q07869 4/20 0.34
GPR84 Q9NQS5 3/20 0.34
HDAC11 Q96DB2 3/20 0.34
TDP1 Q9NUW8 2/20 0.34
SLC22A6 Q4U2R8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acrylic Acid SCHEMBL29670996 1.00 ZDHHC20 (0.39) ZDHHC20ZDHHC2LMNATSHRALDH1A1
Acrylic Acid SCHEMBL29670990 0.98 ZDHHC20 (0.42) ZDHHC20ZDHHC2TSHRALDH1A1CES2
Acrylic Acid SCHEMBL29670980 0.98 ZDHHC20 (0.42) ZDHHC20ZDHHC2TSHRALDH1A1CES2
Acrylic Acid SCHEMBL30415767 0.94 LMNA (0.40) ZDHHC20ZDHHC2LMNATSHRALDH1A1
Acrylic Acid SCHEMBL1726728 0.93 ZDHHC20 (0.37) ZDHHC20ZDHHC2LMNATSHRALDH1A1
Hexane SCHEMBL10822303 0.90 LMNA (0.43) ZDHHC20ZDHHC2LMNATSHRALDH1A1
Acrylic Acid SCHEMBL1776562 0.87 LMNA (0.37) ZDHHC20ZDHHC2LMNATSHRALDH1A1
Acrylic Acid SCHEMBL11317649 0.86 LMNA (0.43) ZDHHC20ZDHHC2LMNATSHRALDH1A1
Acrylic Acid SCHEMBL29670985 0.86 LMNA (0.43) ZDHHC20ZDHHC2LMNATSHRALDH1A1
Acrylic Acid SCHEMBL31043062 0.86 LMNA (0.43) ZDHHC20ZDHHC2LMNATSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250155808-A1 RESIST COMPOSITION AND METHOD OF FORMING RESIST PATTERN ZEON CORPORATION (JP) 2025-05-15 US disclosed
WO-2024070672-A1 RESIST COMPOSITION AND METHOD FOR FORMING RESIST PATTERN 日本ゼオン株式会社 2024-04-04 WO disclosed
EP-3932906-B1 NOVEL COMPOUND, COMPOSITION CONTAINING SAID COMPOUND, AND CURED OBJECT ADEKA CORP (JP) 2023-07-12 EP disclosed
US-11667609-B2 Compound, composition containing said compound, self-healing material, surface coating agent, paint, adhesive, material for battery and cured product ADEKA CORPORATION (JP) 2023-06-06 US disclosed
US-20220153698-A1 NOVEL COMPOUND, COMPOSITION CONTAINING SAID COMPOUND, SELF-HEALING MATERIAL, SURFACE COATING AGENT, PAINT, ADHESIVE, MATERIAL FOR BATTERY AND CURED PRODUCT ADEKA CORPORATION (JP) 2022-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667609-B2 Compound, composition containing said compound, self-healing material, surface coating agent, paint, adhesive, material for battery and cured product H1-0, H1-10, RAD51 ZDHHC20 1613/4885ZDHHC2 2280/4885LMNA 2828/4885
US-20220153698-A1 NOVEL COMPOUND, COMPOSITION CONTAINING SAID COMPOUND, SELF-HEALING MATERIAL, SURFACE COATING AGENT, PAINT, ADHESIVE, MATERIAL FOR BATTERY AND CURED PRODUCT H1-0, H1-10, RAD51 ZDHHC20 1546/4885ZDHHC2 2369/4885LMNA 3038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.